Stem Cells International / 2015 / Article / Tab 2

Clinical Study

Safety of Allogeneic Umbilical Cord Blood Stem Cells Therapy in Patients with Severe Cerebral Palsy: A Retrospective Study

Table 2

Analysis of blood test before and after allogeneic UCBSCs treatment.

ParameterBefore treatment () (%)After treatment () (%) value (two sides)Reference range

Leukocytes8 (17.0%)13 (27.7%)0.322(5.0~12.0) × 109/L
Erythrocytes3 (6.4%)8 (17.0%)0.198(4.0~5.5) × 1012/L
Haemoglobin5 (10.6%)7 (14.9%)0.759(110.0~150.0) g/L
Platelets29 (61.7%)23 (48.9%)0.300(100.0~300.0) × 109/L
ALT3 (6.4%)5 (10.6%)0.714(9~50.0) U/L
AST6 (12.8%)5 (10.6%)1.000(15~40.0) U/L
BUN8 (17.0%)6 (12.8%)0.773(1.43~6.78) mmol/L
SCR2 (4.3%)2 (4.3%)1.000(16.0~73.0) umol/L
K+3 (6.4%)5 (10.6%)0.714(3.5~5.3) mmol/L
Na+6 (12.8%)10 (21.3%)0.206(137.0~147.0) mmol/L
CL4 (8.5%)5 (10.6%)1.000(99.0~110.0) mmol/L
TCO216 (34.0%)13 (27.7%)0.656(20.0~28.0) mmol/L
Glu 3 (6.4%)2 (4.3%)1.000(3.9~6.1) mmol/L
PT4 (8.5%)4 (8.5%)1.000(10.0~13.0) s
APTT 11 (23.4%)10 (21.3%)1.000(22.0~32.0) s
INR1 (2.1%)3 (6.4%)0.3080.8–1.2
FIB5 (10.6%)8 (17.0%)0.552(2.0~4.0) g/L

The numbers (percentage) of patients whose blood test result was abnormal; UCBSCs: umbilical cord blood stem cells; ALT: alanine aminotransferase; AST: aspartate aminotransferase; BUN: serum urea nitrogen; SCR: serum creatinine; K+: serum potassium; Na+: serum sodium; CL: serum chloride ion; TCO2: total carbon dioxide; Glu: serum glucose; PT: prothrombin time; APTT: activated partial thromboplastin time; INR: international normalized ratio; FIB: fibrinogen.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.